Revolution Medicines, Inc. (RVMDW) Net income 2018–2025
Revolution Medicines, Inc. (RVMDW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$1.1BFY2025 · since FY2018: -$41.8M → -$1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.1B | -88.5% |
| FY2024 | -$600.1M | -37.5% |
| FY2023 | -$436.4M | -75.5% |
| FY2022 | -$248.7M | -32.9% |
| FY2021 | -$187.1M | -73.0% |
| FY2020 | -$108.2M | -126.9% |
| FY2019 | -$47.7M | -14.1% |
| FY2018 | -$41.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMDW financial trends
RVMDW RevenueRVMDW Net marginRVMDW Gross profitRVMDW Gross marginRVMDW Operating incomeRVMDW Operating marginRVMDW Operating cash flowRVMDW Free cash flowRVMDW Capital expendituresRVMDW Return on equityRVMDW Stock buybacksRVMDW Dividends paidRVMDW Total assetsRVMDW Total liabilitiesRVMDW Shareholders’ equityRVMDW overview →